Rockwell Medical Inc (RMTI) Stock Forecast & Price Target
Rockwell Medical Inc · NASDAQ
$8.09+0.19 (+2.41%)
15-min delayed · Aug 25, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering Rockwell Medical Inc, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $20.00 to $20.00, so the covering firms are broadly aligned. The average target of $20.00 sits 147% above the current $8.09. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.15 next quarter toward $-0.17 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Strong Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to Rockwell Medical Inc.
As of Aug, 1 of 1 firms rate RMTI a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
RMTI EPS & revenue forecast
EPS · NEXT QUARTER
$-0.15
Range $-0.15 – $-0.15 · 1 analysts · +50% YoY
Next period, 1 analysts expect Rockwell Medical Inc to earn $-0.15 a share (range $-0.15 – $-0.15), versus $-0.10 a year earlier. Full-year consensus is $-1.12, growing to $-0.17 the year after.
REVENUE · NEXT QUARTER
$19.0M
Range $19.0M – $19.1M · 1 analysts · +4% YoY
Revenue is expected to reach $19.0M (range $19.0M – $19.1M), +3.8% year-over-year. Full-year consensus is $72.5M, rising to $78.3M next year.
Top analysts covering Rockwell Medical Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on RMTI.
#1
Raghuram Selvaraju
HC Wainwright & Co. · Rank #294
Buy
$20.00+147.2% to target
Overall win rate
37%
+ Follow
#2
Anthony Vendetti
Maxim Group · Rank #350
Buy
$40.00+394.4% to target
Overall win rate
29%
+ Follow
#3
BF
Brandon Folkes
Rodman & Renshaw
Buy
$5.00-38.2% to target
Coverage
—
+ Follow
RMTI stock forecast FAQ
What is RMTI's average 12-month price target?+
The 1 analysts with a live target average $20.00 for Rockwell Medical Inc over the next 12 months, ranging from a $20.00 high to a $20.00 low.
Is RMTI stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover RMTI?+
1 analysts have an active rating on Rockwell Medical Inc, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering RMTI?+
Among analysts who currently cover RMTI, Raghuram Selvaraju of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #294). Their current call is Buy with a $20.00 target.
What is Rockwell Medical Inc's projected EPS for next quarter?+
The consensus estimate is $-0.15 per share (range $-0.15 – $-0.15) across 1 analysts. Full-year EPS is projected at $-1.12, rising to $-0.17 the following year.
How much revenue is Rockwell Medical Inc expected to report next quarter?+
Consensus revenue is $19.0M (range $19.0M – $19.1M). Full-year revenue is projected at $72.5M, growing to $78.3M next year.
Have analysts been upgrading or downgrading RMTI lately?+
As of Aug, 1 of 1 firms rate RMTI a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their RMTI calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
